|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion显示文摘 | Marcello Deraco MD Daisuke Nonaka MD Dario Baratti MD Paolo Casali MD Juan Rosai MD Rami Younan MD Andreola Salvatore MD Antonello D. Cabras AD MD Shigeki Kusamura MD | 2006 | Annals of Surgical Oncology2006，，2： | 2 |
| 2 | Lactose malabsorption and intolerance: What should be the best clinical management?显示文摘Lactose malabsorption (LM) is the incomplete hydrolysis of lactose due to lactase deficiency, which may occur as a primary disorder or secondary to other intestinal diseases. Primary adult-type hypolactasia is an autosomal recessive condition resulting from the physiological decline of lactase activity. Different methods have been used to diagnose LM. Lactose breath test represents the most reliable technique. A recent consensus conference has proposed the more physiological dosage of 25 g of lactose and a standardized procedure for breath testing. Recently a new genetic test, based on C/T13910 polymorphism, has been proposed for the diagnosis of adult-type hypolactasia, complementing the role of breath testing. LM represents a wellknown cause of abdominal symptoms although only some lactose malabsorbers are also intolerants. Diagnosing lactose intolerance is not straightforward. Many non-malabsorber subjects diagnose themselves as being lactose intolerant. Blind lactose challenge studies should be recommended to obtain objective results. Besides several studies indicate that subjects with lactose intolerance can ingest up to 15 g of lactose with no or minor symptoms. Therefore a therapeutic strategy consists of a lactose restricted diet avoiding the nutritional disadvantages of reduced calcium and vitamin intake. Various pharmacological options are also available. Unfortunately there is insufficient evidence that these therapies are effective. Further double-blind studies are needed to demonstrate treatment effectiveness in lactose intolerance. | Paolo Usai-Satta Mariella Scarpa Francesco Oppia Francesco Cabras | 2012 | World Journal of Gastrointestinal Pharmacology and Therapeutics2012，3，3： | 2 |
| 3 | Validation and global uncertainty of a liquid chromatographic with diode array detection method for the screening of azoxystrobin, kresoxim-methyl, trifloxyslrobin, famoxadone, pyraclostrobin and fenamidone in grapes and wine显示文摘 | SUSANA DE MELO ABREU PIERLUIGI CABONI PAOLO CABRAS | 2006 | Analytica Chimica Acta2006，，： | 1 |
| 4 | Pesticide residues in grapes,wineand their processing products显示文摘 | PAOLO CABRAS ALBERTO ANGIONI | 2000 | J Aspic Food Chem2000，48，4： | 1 |
| 5 | Validation and global uncertainty of a liquid chromatographic with diode array detection method for the screening ofazoxystrobin, esoxim-methy, rifloxystrobin, famoxadone pyraclostrobin and fenamidone in grapes and wine显示文摘 | Susana de Melo Abrou Pierluigi Caboni Paolo Cabras | 2006 | Analytica Chimica Acta2006，，： | 1 |
| 6 | Validation and globl uncertainty of a liquid chromatographic with diode array detection method for the screening of azoxystrobin,kresoxim-methyl,trifloxystrobin,famoxadone, pyraclostrobin and fenamidone in grapes and wine显示文摘 | Susana de Melo Abreu Pierluigi Caboni Paolo Cabras | 2006 | Analytica Chimica Acta2006，，573574： | 1 |
| 7 | Pesticide residues in grapes,wine and their processing products显示文摘 | Paolo Cabras Alberto Angioni | 2000 | J Agric Food Chem2000，，48： | 1 |
| 8 | Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion显示文摘 | Marcello Deraco MD Daisuke Nonaka MD Dario Baratti MD Paolo Casali MD Juan Rosai MD Rami Younan MD Andreola Salvatore MD Antonello D. Cabras AD MD Shigeki Kusamura MD | 2006 | Annals of Surgical Oncology2006，，2： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员